Recent Posts
- Perspective Therapeutics to Present at the 2023 International Symposium on Radiopharmaceutical Sciences (iSRS)
- Perspective Therapeutics Reports First Quarter Fiscal 2023 Results
- Perspective Therapeutics Announces Changes to the Board of Directors
- Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc.
- Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc.
Recent Comments